Percutaneous Needle Electrolysis (PNE) in Soleus Injury

October 7, 2020 updated by: Blanca de la Cruz Torres, University of Seville

Effect of the Application of Ultrasound-guided Percutaneous Needle Electrolysis on the Chronic Soleus Injury in Dancers

This study evaluates if the physiotherapy treatment based on eccentric exercise, ultrasound-guided PNE or a combination of both therapies on chronic soleous injuries may cause changes in pain, functionality, dorsal flexion of the foot, balance and muscle fatigue in dancers.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seville, Spain, 41009
        • University of Seville

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 26 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over 16 years.
  • at least 5 years of formal dance training.
  • at least 20 hours of training per week.
  • Pain in the back of the leg
  • diagnosis of chronic soleus injury

Exclusion Criteria:

  • Unsurpassed fear of needles
  • History of adverse reactions to needles
  • Immune system disorder
  • Difficulty expressing your feelings properly
  • Epilepsy and / or allergies to metals.
  • Other lower limbs pathology

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Eccentric group
The dancers of this group wil perform a soleus eccentric exercise
soleus eccentric exercise
Experimental: PNE group

The dancers of this group will receive a PNE treatment, consisting of the application of galvanic current, by ultrasound.

The approach will be performed with a transverse axis with a needle orientation that will depend on the location of the target tissue. The parameters will be 3 mA, 3 seconds, 3 impacts (3: 3: 3). The periodicity will be 1day/7day/21day

the application of galvanic current
Experimental: Combined group
The dancers of this group will receive a combined treatment and will be carried out in the same way as the other two groups.
soleus eccentric exercise and PNE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of pain level
Time Frame: Change from Baseline VAS at 3 months months
Visual Analogue Scale (VAS: 0=no pain; 100= pain as bad as can be
Change from Baseline VAS at 3 months months
Change of Lunge Test
Time Frame: Change from Baseline lunge test at 3 months months
This test measures the ankle range of motion. Less than 9/10 cm, range of motion will be considered restricted
Change from Baseline lunge test at 3 months months
Change of the Releve test
Time Frame: Change from Baseline releve test at 3 months months
During the unilateral balance test with open eyes, the participant will be asked to hold as much time as possible in the relay position (raised heel of the floor) on one leg
Change from Baseline releve test at 3 months months
Change of the Endurance test
Time Frame: Change from Baseline endurance test at 3 months months
The unilateral raised heel test. The dancer should repeatedly lift the heel from the floor to the maximum range of plantar flexion movement as many times as possible.
Change from Baseline endurance test at 3 months months
Change of the Balance test
Time Frame: Change from Baseline balance test at 3 months months
The test will be conducted with closed eyes, flat feet and barefoot participants and dancers will perform a retiré position. Participants will maintain the position as long as possible.
Change from Baseline balance test at 3 months months
Changes of the DFOS questionnaire
Time Frame: Change from Baseline DFOS questionnaire at 3 months months
This questionnaire measures the pain and function (0= bad; 90=well)
Change from Baseline DFOS questionnaire at 3 months months
Change of the Minimal Detectable Change (MCD)
Time Frame: Change from after treatment at 3 months months
The minimal detectable change is defined as a valid change in score that is not due to chance. Minimally clinically important difference (MCID), in comparison, goes beyond valid change to assess meaningful difference in dance function
Change from after treatment at 3 months months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

July 27, 2019

First Submitted That Met QC Criteria

July 30, 2019

First Posted (Actual)

August 1, 2019

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 7, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PNE in soleus

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Soleus Injury

Clinical Trials on Eccentric exercise

Subscribe